Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy-Reference-Cited by-同舟云学术

Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy

Published:2023-09 Issue: Volume: Page:
ISSN:2451-9456
Container-title:Cell Chemical Biology
language:en
Short-container-title:Cell Chemical Biology

Author:

Yu Haisheng,Liu Jing,Bu Xia,Ma Zhiqiang,Yao Yingmeng,Li Jinfeng,Zhang Tiantian,Song Wenjing,Xiao Xiangling,Sun Yishuang,Xiong Wenjun,Shi Jie,Dai Panpan,Xiang Bolin,Duan Hongtao,Yan Xiaolong,Wu Fei,Zhang Wen Cai,Lin Dandan,Hu Hankun,Zhang Haojian,Slack Frank J.,He Housheng Hansen,Freeman Gordon J.,Wei Wenyi,Zhang Jinfang^ORCID

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,Molecular Medicine,Biochemistry

Reference56 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA A Cancer J. Clin.,2021

2. The biology and management of non-small cell lung cancer;Herbst;Nature,2018

3. Tumor Immunology and Immunotherapy of Non-Small-Cell Lung Cancer;Cascone;Cold Spring Harb. Perspect. Med.,2022

4. Toward personalized treatment approaches for non-small-cell lung cancer;Wang;Nat. Med.,2021

5. Understanding the tumor immune microenvironment (TIME) for effective therapy;Binnewies;Nat. Med.,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Refining the role of N6-methyladenosine in cancer;Current Opinion in Genetics & Development;2024-10

2. METTL3 inhibition-activated cGAS/STING axis enhances immunotherapy and PARP inhibitor sensitivity of lung carcinoma;2024-09-06

3. Writers, readers, and erasers RNA modifications and drug resistance in cancer;Molecular Cancer;2024-08-30

4. N6-methyladenosine in DNA promotes genome stability;2024-07-20

5. PD-L1 at the crossroad between RNA metabolism and immunosuppression;Trends in Molecular Medicine;2024-07